• Scheduled traffic (RPK) increased 9.6% and the capacity (ASK) was up by 9.8%. • The load factor decreased by 0.2 p.u. to 69.3%. • SAS carried 2.2 million scheduled passengers in November, up 3.7%. • The preliminary currency adjusted yield and PASK were both down 7% and the nominal yield and PASK were down 8% in November 2015. Market development and commentary Demand has been positive in Scandinavia during 2015. Overall market capacity has gradually started to increase during the last months and this trend is expected to continue, primarily on international routes. While the competition remains very intensive in certain markets and the demand in regions with high exposure to the oil sector is weaker, demand for leisure oriented routes and SAS long haul traffic is growing. In response to the growing demand, SAS is increasing its intercontinental capacity by about 25% during the winter program through new routes and frequencies already announced. Also, until April 2016 larger aircraft will replace phased out Boeing 717 primarily in Sweden. Overall, this will result in a longer average stage length with subsequent effect on the yield/PASK and contribute to an expected scheduled capacity growth of 10-12% during the winter program. Excluding the long haul expansion the capacity growth is 3-4%. The total number of flights will however only increase by about 1%. PASK and yield development Oct-Nov In October 2015, SAS’ currency adjusted yield and PASK were down 4.3% and 1.3% respectively. From November 2015, SAS will report PASK and yield for the same month as the reported traffic development as shown in the table on the right. SAS scheduled traffic development in November SAS increased its scheduled capacity in November by 9.8%. The traffic responded well and increased by 9.6%, primarily driven by growth on intercontinental routes. The overall load factor declined marginally by 0.2 p.u. to 69.3% mainly due to lower load factors on certain European routes. SAS intercontinental capacity was increased 19.2% and the traffic grew 19.6%. The growth was driven by the new route between Stockholm and Hong Kong and more frequencies on existing routes. On European/ Intrascandinavian routes, capacity was increased by 6.9%. Traffic grew well, but did not match the capacity growth primarily in the Belgian and UK/Irish market. Demand continued to be strongest on leisure routes and on routes to/from Sweden. Domestic traffic was up 2.9%, and capacity was increased 3%.
SAS traffic figures - November 2015 • Scheduled traffic
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
BEN Appoints Healthcare Leader Richard S. Isaacs to Board
BEN Welcomes Richard S. Isaacs to Its Board of Directors Brand Engagement Network Inc. (“BEN”), listed on Nasdaq as BNAI, has announced that Richard S. Isaacs, MD, FACS, has joined its Board of Directors. Dr. Isaacs is a distinguished surgeon who currently serves as the Dean of the College of Medicine and a Professor of Otolaryngology at California Northstate...
Continue Reading
Vue and Barco Partner for Next-Gen Cinema Experience Across Europe
Vue and Barco Collaborate for a Unique Cinematic Experience New premium large format experience 'EPIC' features Barco's premium HDR cinema technology Barco, a leading provider of laser cinema, has partnered with Vue, the largest privately owned cinema operator in Europe, to announce an expansive agreement aimed at enhancing cinema experiences across the continent. This...
Continue Reading
Walovi's Singapore HQ: Key to Southeast Asian Growth
Global Stage With a Southeast Asian Focus You know, I’ve seen my share of companies trying to inject new life into their brands by going global. But what Walovi is doing is no half-measure. Setting up shop in Singapore as its international HQ? That's rolling the dice on a big future. They're not just expanding overseas; they're making Singapore the nerve center of their...
Continue Reading
Vivani Medical Unveils Exciting Future with Cortigent Spin-off
Vivani Medical's Bold Move Towards Innovation Cortigent is making waves in the field of brain implant technologies, establishing itself as a pioneer in precision neurostimulation. Notably, it stands as the sole developer with FDA approval for a device that delivers artificial vision to profoundly blind individuals. A Mission to Transform Lives The Cortigent Orion...
Continue Reading
Week 32 Highlights of American Progress Under Trump
Week 32: Celebrating American Achievements This week has been nothing short of thrilling as we step into Week 32 of America’s journey under the leadership of the Trump Administration. It’s hard to believe that it has already been over thirty weeks since President Trump was inaugurated. Each moment of this remarkable journey has seen an emphasis on revamping our...
Continue Reading